What's in Jiangsu Famous Medical Technology Co., Ltd.'s pipeline?

Jiangsu Famous Medical Technology Co., Ltd. has 13 drugs in our index: 4 marketed, 0 filed, 4 in Phase 3, 3 in Phase 2, 2 in Phase 1.

Which companies overlap with Jiangsu Famous Medical Technology Co., Ltd.'s portfolio?

Top competitors by shared drug class: Ain Shams Maternity Hospital, Arrevus Inc., China Academy of Chinese Medical Sciences, Dongzhimen Hospital, Beijing, Guang'anmen Hospital of China Academy of Chinese Medical Sciences.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangsu-famous-medical-technology-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jiangsu Famous Medical Technology Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jiangsu Famous Medical Technology Co., Ltd. pipeline: 4 marketed, 0 filed, 4 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 4 Phase 3 3 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Wulingsan co-decoction granules	Wulingsan co-decoction granules	marketed
Wulingsan single decoction granules	Wulingsan single decoction granules	marketed
Huperzine A for Injection	Huperzine A for Injection	marketed
Wulingsan granule simulant	Wulingsan granule simulant	marketed		Herbal/Traditional Medicine
Tanreqing capsule	Tanreqing capsule	phase 3	Traditional Chinese medicine	Respiratory
XLJDOD compound granule	XLJDOD compound granule	phase 3
placebo (XLJDOD mimetic agent)	placebo (XLJDOD mimetic agent)	phase 3
Tanreqing capsule simulator	Tanreqing capsule simulator	phase 3	Traditional Chinese medicine	Respiratory

Therapeutic area mix

Respiratory · 2
Herbal/Traditional Medicine · 1
Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams Maternity Hospital · 1 shared drug class
Arrevus Inc. · 1 shared drug class
China Academy of Chinese Medical Sciences · 1 shared drug class
Dongzhimen Hospital, Beijing · 1 shared drug class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 shared drug class
Hospital de Clinicas de Porto Alegre · 1 shared drug class
Shanghai University of Traditional Chinese Medicine · 1 shared drug class
Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiangsu Famous Medical Technology Co., Ltd.:

Cite this brief

Drug Landscape (2026). Jiangsu Famous Medical Technology Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangsu-famous-medical-technology-co-ltd. Accessed 2026-05-17.